Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Bayesian network analyses of resistance pathways against efavirenz and nevirapine.

AIDS (London, England) - 18 Oct 2008

Deforche Koen, Camacho Ricardo J, Grossman Zehave, Soares Marcelo A, Van Laethem Kristel, Katzenstein David A, Harrigan P Richard, Kantor Rami, Shafer Robert, Vandamme Anne-Mieke

Abstract excerpt

OBJECTIVE: To clarify the role of novel mutations selected by treatment with efavirenz or nevirapine, and investigate the influence of HIV-1 subtype on nonnucleoside reverse transcriptase inhibitor (nNRTI) resistance pathways. DESIGN: By finding direct dependencies between treatment-selected muta...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Alkynes
Share to Anti-HIV Agents
Share to Benzoxazines

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cyclopropanes

Share to Databases, Factual

Share to HIV Reverse Transcriptase

Share to Nevirapine

Share to Reverse Transcriptase Inhibitors

Source

Open in PubMed Open full text

Identifiers

PMID: 18832874
DOI: 10.1097/QAD.0b013e32830fe940
PMCID: PMC4788388

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-18832874-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Bayesian network analyses of resistance pathways against efavirenz and nevirapine.PMID 18832874Read ↗

Bayesian network analysis of resistance pathways against HIV-1 protease inhibitors.Semantic proximity Read ↗

Analysis of HIV-1 pol sequences using Bayesian Networks: implications for drug resistance.Semantic proximity Read ↗

Resistance patterns selected by nevirapine vs. efavirenz in HIV-infected patients failing first-line antiretroviral treatment: a bayesian analysis.Semantic proximity Read ↗

Discovering human immunodeficiency virus mutational pathways using temporal Bayesian networks.Semantic proximity Read ↗

Exploring resistance pathways for first-generation NS3/4A protease inhibitors boceprevir and telaprevir using Bayesian network learning.Semantic proximity Read ↗

Constrained patterns of covariation and clustering of HIV-1 non-nucleoside reverse transcriptase inhibitor resistance mutationsSemantic proximity Read ↗

Transmitted drug resistance in the CFAR network of integrated clinical systems cohort: prevalence and effects on pre-therapy CD4 and viral load.Semantic proximity Read ↗

Comparing mutational pathways to lopinavir resistance in HIV-1 subtypes B versus CSemantic proximity Read ↗

A phylogenetic and Markov model approach for the reconstruction of mutational pathways of drug resistance.Semantic proximity Read ↗

Panel of prototypical recombinant infectious molecular clones resistant to nevirapine, efavirenz, etravirine, and rilpivirine.Semantic proximity Read ↗

A Bayesian network approach to study host and viral genetic correlates of HIV-1 disease progressionSemantic proximity Read ↗

Bayesian analysis of complex interacting mutations in HIV drug resistance and cross-resistance.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.